






















Objective: Bipolar disorder is a severe, disabling, and recurring disorder. 
Some studies have shown that the frequency of bipolar disorder in patients with medical diseases is higher than healthy 
controls. The aim of this study was to investigate the frequency of bipolar disorders in medically ill patients hospitalized in 
Iranian general hospitals. 
Method: In this cross sectional study, 697 inpatients (342 men, 49.1%) from different wards of 3 general hospitals, with 
the mean age of 39.3+-10, were enrolled in the study using nonprobability sampling. Demographic questionnaire, Mood 
Disorder Questionnaire (MDQ) and Bipolar Spectrum Diagnostic Scale (BSDS) were used. Inclusion criteria were as 
follow: informed consent, age 18-65 years, ability to speak Persian, and having at least middle school education. 
Results: The frequency of bipolar disorder was 12.1% and 20.8% based on BSDS and MDQ, respectively. The results of 
both tests were positive in 7.9% of hospitalized patients. 
The frequency of bipolar mood disorder was significantly higher in single patients and in those with comorbidity of alcohol 
and substance use disorders. 
Conclusion: Considering the high frequency of bipolar mood disorders in hospitalized medically ill patients and its 
probable effects on compliance and prognosis, early screening, diagnosis, and treatment of bipolar mood disorders is 
important in these patients. 
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Epidemiological studies have a high priority in 
determining national and international policies and are 
inspiring and directional in clinical and basic 
investigations and researches. The role of 
epidemiological studies is important in defining 
disorders, revealing pathology, describing risk factors, 
and creating a vision about different therapeutic aspects 
(1).  
Bipolar disorder is known as manic depression in the 
third edition of Diagnostic and Statistical Manual of 
Mental Disorders (DSM), and although some studies 
consider continuity between bipolar disorder and 
depressive disorders, the clinicians usually split mood 
disorders into 2 divisions: (1) bipolar disorders, (2) 
depressive disorders (2, 3).  
Bipolar disorder is a serious, disabling, and recurring 











biological and psychological tr eatments, it has a high 
rate of morbidity and mortality (5). Also, it can cause 
functional and psychological disability (6) and increase 
the risk of suicide (7). According to the undermining and 
recurrent nature of bipolar disorder (8), early diagnosis 
and intervention may reduce its negative consequences.  
The prevalence of bipolar disorder in general population 
is different among studies. Hardoon et al. (9) stated that 
these different statistics may be due to various sampling 
methods, various diagnostic tools, locational diversity, 
and varied observational periods. Blanco et al. (10) 
found the 12-month prevalence of bipolar disorder type 
1 to be 1/5% to 2/1%, based on DSM- 5 criteria, and 
found no difference between males and females.  
The aggregate lifetime prevalence of all types of bipolar 
disorder was reported to be 5% (11). Previous studies 
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medical diseases and psychiatric disorders (12) which 
decrease quality of life (13) and increase morbidity and 
mortality (14). Despite the increasing number of studies 
on bipolar disorders in psychiatric outpatient and 
inpatient settings, our knowledge about the rate of 
bipolar disorder through medical settings is limited (15). 
The related epidemiological researches imply that 
bipolar disorder type 1 is highly comorbid with alcohol 
dependency (16), substance use disorders (17), and 
suicide (18). In addition, McElroy and Keck (19) studied 
medical comorbidities of bipolar disorder and showed 
that this disorder is concomitant with cardiovascular 
diseases, diabetic type 2, and metabolic syndrome. In 
agreement with their study, Gálvez et al. (20) presented 
that the rate of obesity in bipolar patients is more than 
the general population. In addition, other studies 
indicated that bipolar disorder is also associated with 
other medical disorders, including epilepsy (21), chronic 
pain (22), liver diseases (23), neurologic diseases, 
pulmonary diseases (including asthma and chronic 
obstructive pulmonary disease), endocrine diseases 
(including hyperthyroidism), kidney diseases, 
gastrointestinal diseases, and AIDS (24).  
The aim of this study was to investigate the frequency of 
bipolar disorder in medical patients hospitalized in 
general hospitals of Iran University of Medical Sciences. 
 
Materials and Methods 
This was a descriptive epidemiological study. The target 
sample of this study was the medical inpatients of 
Rasoul-Akram, Firoozabadi, and Firoozgar hospitals. 
The sample included 706 patients who were selected 
using nonprobability sampling. Inclusion criteria were as 
follow: age 18-65 years, ability to speak Persian, and 
having at least middle school education. However, being 
mentally retarded, having cognitive disorders (such as 
dementia and delirium), being admitted to ICU and CCU 
were determined as exclusion criteria. Written informed 
consent was obtained from all the patients. 
The research instruments were 3 questionnaires, 
including Demographic Questionnaire, the Persian 
version of Mood Disorder Questionnaire, and Bipolar 
Spectrum Diagnostic Scale . 
Mood Disorder Questionnaire (MDQ): This self-
reporting scale, which was designed by Hirschfield et al. 
in 2000, is a useful screening tool for diagnosing bipolar 
disorder and should be filled by patients. This scale 
includes 3 parts. The first part includes 13 questions and 
screens the patients based on the symptoms of mania or 
hypomania throughout the life time. The second part of 
the questionnaire determines the existence of current 
mania and hypomania symptoms. The third part checks 
the effect of the disorder in overall function. The 
questionnaire’s overall reliability by means of Cronbach 
alpha equaled 0.81. The sensitivity and specificity were 
calculated to be 67% and 76%, respectively. The 
psychometric properties of the Persian version of this 
questionnaire were reported by Masaeli et al. (25). 
Bipolar Spectrum Diagnostic Scale (BSDS): This 
questionnaire is a bipolar spectrum screening scale and 
includes 2 parts. The first part starts with a short story by 
addressing the patient as a third person and contains 19 
sentences, including the subtle symptoms of bipolar 
disorder. In case the person could relate to a sentence, 1 
point is given to him/her. The second part, which include 
multiple-choice questions, is given to the person upon 
the appropriate score which ranges from 0 to 6. The 
maximum acquirable scores is 25. According to Shabani 
et al. (26) study, the sensitivity and specificity of the 
Persian Bipolar Spectrum Diagnostic Scale at the cut-off 
point of 14, were 0.52 and 0.79, respectively. 
 
Results 
A total of 760 patients [342 males (49.1%) and 355 
females (50.9%)] enrolled in the study; of them, 9 were 
excluded because of uncompleted data. The mean age of 
the participants was 39.3+-10. With respect to marital 
status, 16.7% were single, 77.3% were married, and 
2.4% and 3.6% were divorced and widowed, 
respectively. Moreover, 273 patients (39.2%) had 
graduated from elementary school, 270 (38.8%) had 
high school diploma, and 154 (22.1%) had a university 
degree. Also, 52.8% of the patients were employed, 
3.3% were unemployed, 36.6% were housewives, and 
7.3% were retired . 
According to BSDS questionnaire, the frequency of 
bipolar disorder was 12.1 in medical inpatients in 
hospitals of Iran University of Medical Sciences; this 
frequency was 20.8 based on the MDQ questionnaire, 
and 7.9% based on both questionnaires. The correlation 
between the 2 scales (BSDS and MDQ) was 0.407. The 
results also revealed that the frequency of bipolar 
disorder based on the BSDS was higher in orthopedic, 
rheumatology, neurosurgery, and pulmonology wards, 
which was 27.1%, 20%, 17.8%, and 17.8% respectively; 
and the least rate of the disorders based on BSDS was in 
urology, dermatology, and ENT (0%). Furthermore, the 
highest frequency of bipolar disorders based on MDQ 
scale was reported in orthopedic (18.6%), pulmonology 
(17.8%), and rheumatology (10%) wards; however, 
comorbidity with bipolar disorder was not diagnosed in 
orology, cardiology, and ENT wards. The chart 1 shows 
the distribution of enrolled participants from each ward. 
According to the results of Table 1, based on BSDS 
scores single patients (19 %) showed a more significant 
bipolar disorder rate compared to the married (10%). 
Also, smokers (25 %) showed a more significant bipolar 
disorder rate compared to non-smokers (10%). Patients 
with alcohol use disorders (40%) demonstrated a more 
significant bipolar disorder rate compared to others 
(10%). Regarding substance use disorders, it was 
concluded that patients with substance use disorders 
(38%) had a more significant bipolar disorder rate 
comorbidity (11%). MDQ scores were a little different 
(Table 2). 
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Chart 1. Bipolar Disorder Frequency in Inpatients of Different Wards 
 
 
Table 1. The Difference of Bipolar Disorder Frequency throughout Various Variables Based on Bipolar 
Spectrum Diagnostic Scale  
 
Variable Level of Difference Chi-Square Test Significance Level 
Gender Male = Female 3.281 0.070 
Marital statues Married < Single 8.912  0.030 
Cigarette smoking No use < Consumer 20.723 0.001 
Alcohol use disorders No use < Consumer 23.103 0.001 
Substance use disorders No use < Consumer 13.856 0.001 
 
 
Table 2. The Difference of Bipolar Disorder Frequency throughout Various Variables Based on Mood 
Disorder Questionnaire 
 
Variable Level of Difference Significance Level Chi-Square Test 
Gender Female < Male 0.027 4.895 
Marital status Married < Single 0.044 8.118 
Smoking No use < Consumer 0.005 7.730 
Alcohol use disorders No use < Consumer 0.008 7.012 
Substance use disorders No use = Consumer 0.373 0.793 
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Discussion 
The aim of this study was to determine the frequency of 
bipolar disorder in hospitals of the medical inpatients in 
Iran University of Medical Sciences. In the BSDS 
questionnaire, the frequency of bipolar disorder was 
12.1%; this rate was 20.8% according to MDQ, and it 
was 7.9% based on the results of both questionnaires . 
If we consider the results of each questionnaire and 
those of other studies (11), which have shown that the 
life time prevalence of bipolar disorder in healthy 
population is about 5%, it can be implied that the 
frequency of bipolar disorder in medical inpatients is 
about 2 to 4 times higher than the general population. In 
a research by Pouretemad et al. (27) in Iran, the rate of 
bipolar mood disorder was 0.8% .Stubbs et al. (28) 
reported that the prevalence of bipolar disorder was 
1.9% in primary care clinics . 
In this study, it was found that the prevalence of bipolar 
disorder in medically ill patients was far more frequent 
than the general population. This finding agrees with 
Carney& Jone (24), McElroy & Keck (19), and Galvez 
et al, (29) who indicated that medical illnesses have a 
high comorbidity with bipolar disorder. It seems that in 
addition to the probability of common basic biological 
and genetic factors, the environmental stressors can also 
be mentioned as one of the probable reasons of this high 
rate of comorbidity . 
In studies on neurobiology of bipolar disorders, it was 
frequently reported that in addition to changes of 
serotonin, dopamine also increases in patients with 
mania or hypomania (30). Furthermore, according to 
Vaessen et al. study (31), the outbreak and increase of 
dopamine was reported in medical illnesses, so it can be 
concluded that medical and bipolar disorder may have 
common neurobiological etiology, and dopamine 
increases in both states . 
In addition, the other probable factor that can be the 
determinant of this high comorbidity is the life style of 
bipolar patients, which exposes them to medical diseases 
more frequently (32). In this regard, it was demonstrated 
that bipolar patients are more vulnerable to obesity, type 
2 diabetes, and cardiovascular diseases because of 
unhealthy diet, and lack of exercise and physical 
activity. (33). Vancampfort et al. (34) also indicated that 
low physical activity and improper diet of bipolar 
patients increase the risk of other medical diseases in 
these patients . 
The other factor that can increase the comorbidity of 
medical diseases in bipolar disorder patients is 
impulsivity. Feki et al. (35) showed that the level of 
impulsivity among bipolar patients in comparison with 
the general population is higher, the rate of impulsivity 
was 55%. Thus, in the present study, the orthopedic 
issues of these patients and higher rate of hospitalization 
of patients with bipolar disorder in the orthopedic ward 
may have been the result of impulsivity and reckless 
behaviors . 
The other issue is the side effects of medication in 
patients with bipolar disorder. Researches have 
confirmed that these medications disturb the metabolic 
process which can lead to medical illnesses (36).  
It was also indicated that the frequency of bipolar 
disorder is more in medically ill males. This finding 
agrees with that of Grant et al. (37) that indicated that 
bipolar disorder type 1 is more frequent in males than in 
females. On the other hand, some researchers have found 
that bipolar disorder type 2 and rapid cycling are more 
common among females (38). These diversities may be 
due to the use of different measuring tools. Moreover, 
different types of bipolar disorder were not differentiated 
in the present study and if this separation had been 
applied, then different results could have been obtained . 
Also, it was shown that bipolar disorder in single 
patients were significantly more frequent compared to 
the married. This finding is in contradiction with some 
other studies. Blanco et al. (11) and Kim et al. (39) have 
declared that the prevalence of bipolar disorder is not 
significantly different between single and married 
patients. Regarding the difference in the results of the 
present study (in medical patients), it can be stated that 
the role of the partner as a protecting factor gains more 
significance and because single individuals are deprived 
from this powerful support, they are more susceptible to 
mental disorders and medical diseases. Besides, in this 
study, it was found that cigarette smoking and alcohol 
and drug use disorders are significantly more frequent 
among the medically ill bipolar patients. The findings of 
this study agree with several researches, which revealed 
a connection among these variables (11, 40-41). Some 
studies have introduced alcohol and drug use disorders 
as susceptive factors in triggering or worsening bipolar 
disorder (42). On the other hand, some other studies 
presented these disorders as the consequence of bipolar 
disorder. Alcohol and drug use disorders are considered 
as some type of self-medication for bipolar patients and 
consequently they can worsen the medical condition and 
create a type of mal-cycle (22). In addition, alcohol and 
drug use disorders can affect the hypothalamus-pituitary-
adrenal axis and may release dopamine (43), leading to 
the aggravation of bipolar symptoms. 
We suggest that the researchers replicate this study by 
paying attention to the categorization of types of bipolar 
disorder and using clinical interview for diagnosis. 
 
Limitation 
Overall, it is suggested to view this study by taking its 
limits into consideration, including not differentiating 
between the types of bipolar disorder, specifically types 
1 and 2. The other limitation of this study was its 
reliance on questionnaire and not using clinical 
interviews. In a study by Carvalho et al. (44) at 
recommended cut-offs, summary sensitivity for the 
MDQ and BSDS was 66% and 69%, while specificity 
was 79% and 86% for both questionnaires, respectively. 
In fact, both of these tests have the potential of “false 
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positives.” Moreover, considering the sampling method, 
the participants in this study were not representative of 
all patients with medical diseases. In addition, the 
questionnaires were difficult to understand for some of 
the patients and we tried to provide explanations to 
them, however, this problem might have affected the 
accuracy of the results. 
 
Conclusion 
The frequency of bipolar mood disorder in medically ill 
patients hospitalized in general hospitals is significant, 
due to the impact of the disorder on the lifestyle, 
treatment adherence, course and the prognosis, 
identification and treatment of bipolar mood disorder is 
important in these patients. 
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